Paul Fortgang, MD
Otolaryngology · New Haven, CTNPI 1649292566
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,694 of the $2,690 with a category attached, or 63.0%. 7 manufacturers reported payments, led by Medtronic at 40.0% of the total. Reporting peaked in 2019 at $1,295 and has fallen 64.9% since, to $455 in 2025.
Across 92 payments — averaging $29.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- GSK$827
- Optinose US, Inc.$190
- Regeneron Healthcare Solutions, Inc.$172
- Intersect ENT, Inc.$163
- Aerin Medical Inc.$140
- plus $121 from 1 others
What the payments were for
- Travel & lodging$99637%
- Food & beverage$1,69463%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 7 | $1,076 |
| GSK | 59 | $827 |
| Optinose US, Inc. | 10 | $190 |
| Regeneron Healthcare Solutions, Inc. | 7 | $172 |
| Intersect ENT, Inc. | 2 | $163 |
| Aerin Medical Inc. | 2 | $140 |
| Sanofi | 5 | $121 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,690 in reported general payments places this provider in the 60th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $6,579 |
| Ipratropium Bromide | 30 | $1,945 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 22 | $997 |
| Fluocinolone Acetonide Oil | 14 | $822 |
| Ofloxacin | 23 | $708 |
| Fluticasone Propionate | 39 | $589 |
| Lidocaine Hcl ViscousLidocaine Hcl | 22 | $441 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 39 | $384 |
| Montelukast Sodium | 26 | $234 |
| Omeprazole | 23 | $219 |
| Amoxicillin | 11 | $66 |
| Prednisone | 18 | $22 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in New Haven
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard BoeyNew Haven$19K
- Wendell YarbroughNew Haven$6K
- Ken YanagisawaNew Haven$5K
- Mark DagostinoNew Haven$5K
- Clarence SasakiNew Haven$5K
- Eaton ChenNew Haven$4K
- Tiffany ChenNew Haven$3K
- Catherine BrophyNew Haven$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.